SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-18-000047
Filing Date
2018-02-06
Accepted
2018-02-05 19:39:18
Documents
61
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp123117form10q.htm 10-Q 595473
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 53592
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 32838
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 59590
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 8230
6 EXHIBIT 31.2 ex31_2.htm EX-31.2 8043
7 EXHIBIT 32.1 ex32_1.htm EX-32.1 4633
8 EXHIBIT 32.2 ex32_2.htm EX-32.2 4633
  Complete submission text file 0001607062-18-000047.txt   3730483

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE rgbp-20171231.xml EX-101.INS 736433
10 XBRL SCHEMA FILE rgbp-20171231.xsd EX-101.SCH 42356
11 XBRL CALCULATION FILE rgbp-20171231_cal.xml EX-101.CAL 38048
12 XBRL DEFINITION FILE rgbp-20171231_def.xml EX-101.DEF 169300
13 XBRL LABEL FILE rgbp-20171231_lab.xml EX-101.LAB 203406
14 XBRL PRESENTATION FILE rgbp-20171231_pre.xml EX-101.PRE 200085
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 18575833
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences